Last reviewed · How we verify
NCT05585177
Growth Hormone to Improve the Clinical Outcome of Assisted Fertility in Young Patients With Decreased Ovarian Reserve
NA trial testing Growth hormone in Infertility in 120 participants. Status unknown.
30 November 2024
Quick facts
| Lead sponsor | Nanjing University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 November 2022 |
| Primary completion | 30 November 2024 |
| Estimated completion | 30 October 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Growth hormone — full drug profile →
Conditions studied
- Infertility — all drugs for Infertility →
Sponsor
Nanjing University
Who can join
Adults 20 to 34, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was a prospective randomized controlled trial. Patients aged \<35 years with decreased clinical reserve function (AFC\<5, Follicle stimulating hormone \> 10miu/ml, Anti-mullerian hormone \< 1.1μg/L) and receiving IVF/ICSI assisted ovulation induction in our hospital were included in this study. After randomization using Excel(Microsoft Corporation, Albuquerque, USA), these patients were divided into two groups. Group A was the experimental group, which was treated with growth hormone for 3 months (2 units per day) before IVF/ICSI. Group B was the control group, which was directly assisted by IVF/ICSI.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05585177
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Growth hormone
Trials testing the same drug.
- NCT05574894 — Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study · Phase 3 · completed
- NCT03966339 — Growth Hormone Adding to Controlled Ovarian Hyperstimulation for Improving Embryo Quality · NA · unknown
- NCT03225755 — Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy · completed
- NCT03616509 — GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition · Phase 4 · completed
- NCT02217345 — Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease · Phase 2 · completed
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other Nanjing University trials
Trials by the same sponsor.
- NCT06571214 — Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment · Phase 4 · not yet recruiting
- NCT07128394 — Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment · NA · recruiting
- NCT06477211 — DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma · completed
- NCT06005207 — Vaginal Progesterone Improves Clinical Outcomes of RIF Patients · NA · unknown
- NCT06174597 — Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05585177 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nanjing University
- Last refreshed: 24 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05585177.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing